Nachrichten zur Pfizer Inc. Aktie

Pfizers 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics

Is Pfizer a yield trap? No way.…

Novavax (NVAX) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DateThursday, Nov. 6, 2025, at 8:30 a.m. ETCall participantsPresident and Chief Executive Officer — John JacobsHead…

Pfizer’s newer medicines carry more weight in Q1

Pfizer’s first-quarter results gave investors a clearer view of how much work the drugmaker’s newer portfolio is doing as the…

Pfizer Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Pfizer nach Zahlen zum ersten Quartal auf "Kaufen" mit…

DZ Bank belässt Pfizer auf Kaufen - Fairer Wert 29 Dollar

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Pfizer nach Zahlen zum ersten Quartal auf "Kaufen" mit…

Pfizer Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 27…

BofA raises Pfizer stock price target on first-quarter beat

BofA raises Pfizer stock price target on first-quarter beat…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Quartalszahlen auf "Neutral" mit einem Kursziel…

ROUNDUP: Neue und alte Medikamente sorgen für überraschendes Wachstum bei Pfizer

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer ist im ersten Quartal überraschend deutlich gewachsen und…

ROUNDUP: Neue und alte Medikamente sorgen für überraschendes Wachstum bei Pfizer

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer ist im ersten Quartal überraschend deutlich gewachsen und sieht sich auf Kurs…

IQVIA (IQV) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, May 5, 2026 at 9 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Ari BousbibExecutive…

Überraschend starker Start: Neue Medikamente sorgen für Wachstum bei Pfizer

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer ist im ersten Quartal überraschend deutlich gewachsen und…

Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidance

Pfizer Inc (NYSE:PFE, XETRA:PFE) reported first-quarter 2026 revenue and adjusted profit above Wall Street expectations on Tuesday, driven by strong…

Pfizer Aktie: Ausblick bestätigt

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.…

Pfizer beats first quarter estimates on strong product growth

Pfizer beats first quarter estimates on strong product growth…

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer on Tuesday reported first-quarter profit ?above Wall Street estimates, boosted by sustained demand for older ?drugs such as blood…

Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth

Pfizer beats Q1 estimates as new launches and acquired drugs lift sales, offsetting COVID declines, while the drugmaker reaffirms its…

Pfizer Stock: Still Priced Like Its Dead Money

Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%.…

US FDA approves Pfizer, Arvinas’ breast cancer drug

US FDA approves Pfizer, Arvinas’ breast cancer drug…

US FDA approves Pfizer, Arvinas breast cancer drug

The U.S. ?Food and Drug Administration ?on Friday approved Pfizer and Arvinas drug for ?a ?type of breast cancer.…

Goldman Sachs resets Pfizer stock forecast

Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own,…

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings

Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support…

Pfizer Aktie: Vyndamax-Deal sorgt für Zweifel an Patentstärke

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley bewerten die Aktie von Pfizer Inc. (ISIN: US7170811035,…

Novo Nordisk vs. Pfizer: Which Healthcare Giant Is the Better Bet?

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping their…

Is Pfizers 6% Dividend Yield Safe? Heres What Investors Need to Know.

Pfizers vaccine business cooled off, and it is on its back foot in the GLP-1 race, but dont count the…

Is Pfizers 6% Dividend Yield Safe? Heres What Investors Need to Know.

Pfizers vaccine business cooled off, and it is on its back foot in the GLP-1 race, but dont count the…

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

The latest trading day saw Pfizer (PFE) settling at $26.8, representing a -1.87% change from its previous close.…

MRKs sBLAs for Keytruda Combo in Bladder Cancer Get FDA Priority Tag

FDA grants priority review to Mercks sBLAs for Keytruda & Keytruda SC in combination with Pfizers Padcev in cisplatin-eligible MIBC…

A Monthly Weight Loss Shot? Why Pfizer Could Topple Lillys and Novos GLP-1 Duopoly

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable…

Pfizers Non-Oncology Portfolio in Focus Ahead of Q1 Earnings

PFEs non-oncology portfolio is in focus ahead of Q1, with Eliquis and Prevnar gains expected to be offset by declines…

Pfizer (PFE) Outperforms Broader Market: What You Need to Know

Pfizer (PFE) reached $27.34 at the closing of the latest trading day, reflecting a +1.56% change compared to its last…

AIM movers: Mothercare suffering and Trellus Health renews Pfizer licence

Mercantile Ports and Logistics (LON: MPL) shares continue to rise while investors await a decision from the meeting of a…

Battle of Big Pharma: Is AbbVie Stock Pulling Ahead of Pfizer?

ABBV edges out PFE as Skyrizi and Rinvoq fuel strong growth, offsetting Humira losses and positioning the drugmaker for sustained…

How Pfizers Oncology Portfolio Is Shaping Up Before Q1 Results

Pfizers oncology unit displays mixed Q1 trends as key drugs and biosimilars offset Ibrance declines ahead of earnings on May…

Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note

Pfizer (PFE) concluded the recent trading session at $27.1, signifying a -2.62% move from its prior days close.…

Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate

The market offers opportunities in targeted therapies, increasing CAR T-cell and monoclonal antibody use, personalized medicine, and infrastructure investments The…

dpa-AFX ProFeed